×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Self-Monitoring Blood Glucose (SMBG) Devices Market Forecast 2027 By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: January 2022   |   Report ID: GR1021   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology

    1.1    Definition and forecast parameters

    1.1.1    Definitions

    1.1.2    Methodology and forecast parameters

    1.2    Data sources

    1.3    References & sources

    1.3.1    Secondary

    1.3.2    Primary

    Chapter 2   Market Summary

    2.1    North America self-monitoring blood glucose (SMBG) devices industry summary, 2016 – 2027

    2.1.1    Country trends

    2.1.2    Product trends

    2.1.3    Application trends

    2.1.4    Distribution channel trends

    Chapter 3   Market Analysis

    3.1    Industry segmentation

    3.2    Industry outlook, 2016 – 2027 (USD Million)

    3.3    Major factor analysis

    3.3.1    Drivers

    3.3.1.1    Individual and national expenditure over diabetes treatment

    3.3.1.2    Technological advancements in self-monitoring glucose devices

    3.3.1.3    Increasing adoption of sedentary lifestyle and rising obese population prone to suffer from diabetes

    3.3.1.4    Growing prevalence of diabetes

    3.3.2    Industry pitfalls & challenges

    3.3.2.1    High cost associated with SMBG devices

    3.4    Analysis of COVID-19 impact on the industry

    3.5    Porter’s analysis

    3.6    Competitive review, 2020

    3.7    PEST analysis

    Chapter 4   North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Product

    4.1    Market trends

    4.2    Self-monitoring blood glucose meters

    4.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    4.3    Continuous glucose monitors

    4.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    4.4    Testing strips

    4.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    4.5    Lancets

    4.5.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    Chapter 5   North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Application

    5.1    Market trends

    5.2    Type 1 diabetes

    5.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    5.3    Type 2 diabetes

    5.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    5.4    Gestational diabetes

    5.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    Chapter 6   North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Distribution Channel

    6.1    Market trends

    6.2    Hospital pharmacies

    6.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    6.3    Retail pharmacies

    6.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    6.4    Online sales

    6.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    6.5    Diabetes Clinics & Centers

    6.5.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

    Chapter 7   North America Self-monitoring Blood Glucose (SMBG) Devices Market, By Country

    7.1    Market trends

    7.2    U.S.

    7.2.1    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

    7.2.2    Market estimates and forecast, by application, 2016 – 2027 (USD Million)

    7.2.3    Market estimates and forecast, by distribution channel, 2016 – 2027 (USD Million)

    7.3    Canada

    7.3.1    Market estimates and forecast, by product, 2016 – 2027 (USD Million)

    7.3.2    Market estimates and forecast, by application, 2016 – 2027 (USD Million)

    7.3.3    Market estimates and forecast, by distribution channel, 2016 – 2027 (USD Million)

    Chapter 8   Company Profiles

    8.1    Abbott Laboratories

    8.1.1    Business overview

    8.1.2    Financial data

    8.1.3    Product landscape

    8.1.4    Strategic outlook

    8.1.5    SWOT analysis

    8.2    Arkray

    8.2.1    Business overview

    8.2.2    Financial data

    8.2.3    Product landscape

    8.2.4    Strategic outlook

    8.2.5    SWOT analysis

    8.3    B. Braun Melsungen AG

    8.3.1    Business overview

    8.3.2    Financial data

    8.3.3    Product landscape

    8.3.4    Strategic outlook

    8.3.5    SWOT analysis

    8.4    Bayer Healthcare

    8.4.1    Business overview

    8.4.2    Financial data

    8.4.3    Product landscape

    8.4.4    Strategic outlook

    8.4.5    SWOT analysis

    8.5    Bionime Corporation.

    8.5.1    Business overview

    8.5.2    Financial data

    8.5.3    Product landscape

    8.5.4    Strategic outlook

    8.5.5    SWOT analysis

    8.6    F. Hoffmann-La Roche AG

    8.6.1    Business overview

    8.6.2    Financial data

    8.6.3    Product landscape

    8.6.4    Strategic outlook

    8.6.5    SWOT analysis

    8.7    Platinum Equity (LifeScan)

    8.7.1    Business overview

    8.7.2    Financial data

    8.7.3    Product landscape

    8.7.4    Strategic outlook

    8.7.5    SWOT analysis

    8.8    Agamatrix Inc

    8.8.1    Business overview

    8.8.2    Financial data

    8.8.3    Product landscape

    8.8.4    Strategic outlook

    8.8.5    SWOT analysis

    8.9    Dexcom

    8.9.1    Business overview

    8.9.2    Financial data

    8.9.3    Product landscape

    8.9.4    Strategic outlook

    8.9.5    SWOT analysis

    8.10    Johnson & Johnson

    8.10.1    Business overview

    8.10.2    Financial data

    8.10.3    Product landscape

    8.10.4    Strategic outlook

    8.10.5    SWOT analysis

    8.11    Medtronic

    8.11.1    Business overview

    8.11.2    Financial data

    8.11.3    Product landscape

    8.11.4    Strategic outlook

    8.11.5    SWOT analysis

    8.12    Nipro Diagnostics

    8.12.1    Business overview

    8.12.2    Financial data

    8.12.3    Product landscape

    8.12.4    Strategic outlook

    8.12.5    SWOT analysis

    8.13    Nova Biomedical

    8.13.1    Business overview

    8.13.2    Financial data

    8.13.3    Product landscape

    8.13.4    Strategic outlook

    8.13.5    SWOT analysis

    8.14    Trividia Health

    8.14.1    Business overview

    8.14.2    Financial data

    8.14.3    Product landscape

    8.14.4    Strategic outlook

    8.14.5    SWOT analysis

    8.15    Sinocare

    8.15.1    Business overview

    8.15.2    Financial data

    8.15.3    Product landscape

    8.15.4    Strategic outlook

    8.15.5    SWOT analysis
     


    Get this research report on North America Self-Monitoring Blood Glucose Devices Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]